UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (186) 186
life sciences & biomedicine (181) 181
oncology (164) 164
humans (153) 153
male (147) 147
female (138) 138
aged (134) 134
middle aged (131) 131
adult (98) 98
lung neoplasms - drug therapy (82) 82
carcinoma, non-small-cell lung - drug therapy (67) 67
lung neoplasms - pathology (67) 67
aged, 80 and over (63) 63
treatment outcome (56) 56
lung cancer (55) 55
chemotherapy (54) 54
retrospective studies (49) 49
cancer (48) 48
lung cancer, non-small cell (48) 48
carcinoma, non-small-cell lung - pathology (47) 47
lung neoplasms - mortality (40) 40
non-small cell lung cancer (40) 40
respiratory system (40) 40
medicine & public health (38) 38
prognosis (38) 38
analysis (35) 35
care and treatment (35) 35
neoplasm staging (35) 35
disease-free survival (34) 34
antineoplastic agents - therapeutic use (33) 33
antineoplastic combined chemotherapy protocols - therapeutic use (30) 30
carcinoma, non-small-cell lung - mortality (30) 30
lung neoplasms - genetics (30) 30
pharmacology & pharmacy (28) 28
mutation (27) 27
patients (25) 25
pulmonary/respiratory (25) 25
cancer research (24) 24
epidermal growth factor (24) 24
carcinoma, non-small-cell lung - genetics (23) 23
metastasis (23) 23
kaplan-meier estimate (22) 22
lung cancer, small cell (22) 22
non-small cell lung carcinoma (21) 21
gefitinib (19) 19
hematology, oncology and palliative medicine (19) 19
protein kinase inhibitors - therapeutic use (19) 19
research (19) 19
tumors (19) 19
pharmacology/toxicology (18) 18
japan (17) 17
non-small-cell lung cancer (17) 17
pulmonary and respiratory medicine (17) 17
radiotherapy (17) 17
survival analysis (17) 17
tyrosine (17) 17
cancer therapies (16) 16
lung neoplasms - metabolism (16) 16
nsclc (16) 16
survival rate (16) 16
antineoplastic combined chemotherapy protocols - adverse effects (15) 15
clinical trials (15) 15
disease progression (15) 15
erbb receptors - genetics (15) 15
studies (15) 15
antineoplastic agents - administration & dosage (14) 14
antineoplastic agents - adverse effects (14) 14
medical research (14) 14
original (14) 14
internal medicine (13) 13
medicine, experimental (13) 13
pathology (13) 13
quinazolines - therapeutic use (13) 13
carcinoma, non-small-cell lung - metabolism (12) 12
cisplatin - administration & dosage (12) 12
drug administration schedule (12) 12
epidermal growth factor receptors (12) 12
immunohistochemistry (12) 12
receptor, epidermal growth factor - genetics (12) 12
time factors (12) 12
dose-response relationship, drug (11) 11
hypoxia (11) 11
lung neoplasms - diagnostic imaging (11) 11
lung neoplasms - surgery (11) 11
research article (11) 11
usage (11) 11
young adult (11) 11
adenocarcinoma - drug therapy (10) 10
chemoradiotherapy (10) 10
diagnosis (10) 10
diagnostic radiology (10) 10
follow-up studies (10) 10
neoplasms - drug therapy (10) 10
original article (10) 10
pharmacokinetics (10) 10
quinazolines - administration & dosage (10) 10
quinazolines - adverse effects (10) 10
radiation therapy (10) 10
receptor, epidermal growth factor - antagonists & inhibitors (10) 10
respiratory tract diseases (10) 10
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Supportive care in cancer, ISSN 1433-7339, 11/2014, Volume 23, Issue 6, pp. 1699 - 1708
Journal Article
Investigational new drugs, ISSN 0167-6997, 07/2018, Volume 37, Issue 1, pp. 184 - 187
Journal Article
Cancer chemotherapy and pharmacology, ISSN 0344-5704, 3/2008, Volume 61, Issue 3, pp. 489 - 496
Journal Article
Cancer chemotherapy and pharmacology, ISSN 0344-5704, 9/2011, Volume 68, Issue 3, pp. 653 - 659
... concentration on chemotherapy-induced nausea and vomiting in Japanese cancer patients Toshiaki Takahashi • Yukiko Nakamura • Asuka Tsuya • Haruyasu Murakami • Masahiro Endo... 
Aprepitant | Dexamethasone | Medicine & Public Health | Substance P | Cancer Research | Oncology | Pharmacology/Toxicology | Pharmacokinetics | Chemotherapy-induced nausea and vomiting | Pharmacology & Pharmacy | Life Sciences & Biomedicine | Science & Technology | Lung Neoplasms - drug therapy | Nausea - chemically induced | Area Under Curve | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Small Cell Lung Carcinoma - complications | Small Cell Lung Carcinoma - drug therapy | Immunoenzyme Techniques | Young Adult | Antiemetics - pharmacokinetics | Antineoplastic Agents - adverse effects | Antiemetics - therapeutic use | Anti-Inflammatory Agents - therapeutic use | Adult | Anti-Inflammatory Agents - pharmacokinetics | Female | Drug Therapy, Combination | Nausea - drug therapy | Granisetron - therapeutic use | Morpholines - therapeutic use | Japan | Vomiting - drug therapy | Mesothelioma - complications | Substance P - blood | Lung Neoplasms - complications | Mesothelioma - drug therapy | Dexamethasone - pharmacokinetics | Carcinoma, Non-Small-Cell Lung - complications | Vomiting - chemically induced | Dexamethasone - therapeutic use | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Morpholines - pharmacokinetics | Cancer patients | Chemotherapy | Analysis | Central nervous system depressants | Nausea | Steroids | Cancer | Index Medicus | Original
Journal Article
International journal of clinical oncology, ISSN 1341-9625, 8/2015, Volume 20, Issue 4, pp. 668 - 673
Journal Article
Cancer science, ISSN 1347-9032, 07/2016, Volume 107, Issue 7, pp. 1001 - 1005
Although third‐generation epidermal growth factor receptor‐tyrosine kinase inhibitors (EGFR‐TKI) can overcome T790M‐mediated resistance in non‐small‐cell lung... 
epidermal growth factor receptor‐tyrosine kinase inhibitors | non‐small‐cell lung cancer | rebiopsy | Disease progression | T790M mutation | Non-small-cell lung cancer | Rebiopsy | Epidermal growth factor receptor-tyrosine kinase inhibitors | epidermal growth factor receptor-tyrosine kinase inhibitors | non-small-cell lung cancer | Life Sciences & Biomedicine | Oncology | Science & Technology | Biopsy - methods | Lung Neoplasms - drug therapy | Humans | Middle Aged | ErbB Receptors - genetics | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | DNA Mutational Analysis | Treatment Failure | Aged, 80 and over | Adult | Female | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | ErbB Receptors - antagonists & inhibitors | Lung Neoplasms - enzymology | Carcinoma, Non-Small-Cell Lung - genetics | Japan | Biopsy - statistics & numerical data | Disease Progression | Drug Resistance, Neoplasm - genetics | Neoplasm Metastasis - pathology | Protein Kinase Inhibitors - therapeutic use | Neoplasm Metastasis - diagnosis | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Non-Small-Cell Lung - enzymology | Clinical Trials as Topic - methods | Mutation | Drug Resistance, Neoplasm - drug effects | Tyrosine | Medical research | Care and treatment | Epidermal growth factor | Analysis | Medicine, Experimental | Phenols | Development and progression | Lung cancer, Non-small cell | Epidermal growth factor receptors | Laboratories | Lung cancer | Cytology | Clinical trials | Non-small cell lung carcinoma | Thorax | Malignancy | Metastasis | Cancer therapies | Patients | Chemotherapy | Cellular biology | Computed tomography | Protein-tyrosine kinase | Index Medicus | Original
Journal Article
Medical oncology (Northwood, London, England), ISSN 1357-0560, 9/2012, Volume 29, Issue 3, pp. 1663 - 1672
Journal Article
Journal Article
Journal Article
Cancer chemotherapy and pharmacology, ISSN 0344-5704, 5/2011, Volume 67, Issue 5, pp. 1119 - 1128
Journal Article